Based on the HCA Holdings Inc stock forecast from 15 analysts, the average analyst target price for HCA Holdings Inc is USD 398.68 over the next 12 months. HCA Holdings Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of HCA Holdings Inc is Slightly Bullish , which is based on 9 positive signals and 4 negative signals. At the last closing, HCA Holdings Inc’s stock price was USD 332.24. HCA Holdings Inc’s stock price has changed by -3.84% over the past week, -19.12% over the past month and +31.31% over the last year.
No recent analyst target price found for HCA Holdings Inc
No recent average analyst rating found for HCA Holdings Inc
Company Overview HCA Holdings Inc
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee. Read Less
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagno...Read More
Frequently Asked Questions About HCA Holdings Inc (HCA) Stock
Based on ratings from 15 analysts HCA Holdings Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 21 buy, sell and 3 hold ratings.
HCA stock's dividend yield is 0.75%.
Our analysis grades HCA stock's dividend yield at D+. This means that HCA stock's dividend yield is above 67% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this HCA may be a average dividend stock for its sector.
Based on targets from 15 analysts, the average taret price for HCA is USD 398.68 over the next 12 months. The maximum analyst target price is USD 460 while the minimum anlayst target price is USD 332.
HCA stock's Price/Earning ratio is 15.90.
Our analysis grades HCA stock's Price / Earning ratio at F. This means that HCA stock's Price/Earning ratio is above 47% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this HCA may be fairly valued for its sector
The last closing price of HCA's stock was USD 332.24.
The most recent market capitalization for HCA is USD 89.71B.
Based on targets from 15 analysts, the average taret price for HCA is projected at USD 398.68 over the next 12 months.
This means that HCA's stock price may go up by +20.00% over the next 12 months.
We can't find any ETFs which contains HCA Holdings Inc's stock.
As per our most recent records HCA Holdings Inc has 220,000 Employees.
HCA Holdings Inc's registered address is One Park Plaza, Nashville, TN, United States, 37203.
You can get more information about it from HCA Holdings Inc's website at https://www.hcahealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Frequently Asked Questions About HCA Holdings Inc (HCA) Stock
Based on ratings from 15 analysts HCA Holdings Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 21 buy, sell and 3 hold ratings.
HCA stock's dividend yield is 0.75%.
Our analysis grades HCA stock's dividend yield at D+. This means that HCA stock's dividend yield is above 67% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this HCA may be a average dividend stock for its sector.
Based on targets from 15 analysts, the average taret price for HCA is USD 398.68 over the next 12 months. The maximum analyst target price is USD 460 while the minimum anlayst target price is USD 332.
HCA stock's Price/Earning ratio is 15.90.
Our analysis grades HCA stock's Price / Earning ratio at F. This means that HCA stock's Price/Earning ratio is above 47% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this HCA may be fairly valued for its sector
The last closing price of HCA's stock was USD 332.24.
The most recent market capitalization for HCA is USD 89.71B.
Based on targets from 15 analysts, the average taret price for HCA is projected at USD 398.68 over the next 12 months.
This means that HCA's stock price may go up by +20.00% over the next 12 months.
We can't find any ETFs which contains HCA Holdings Inc's stock.
As per our most recent records HCA Holdings Inc has 220,000 Employees.
HCA Holdings Inc's registered address is One Park Plaza, Nashville, TN, United States, 37203.
You can get more information about it from HCA Holdings Inc's website at https://www.hcahealthcare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HCA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
